Relmada Therapeutics Inc. (RLMD)
undefined
undefined%
At close: undefined
0.44
0.00%
Pre-market Jan 07, 2025, 05:20 AM EST

Relmada Therapeutics Inc. Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for RLMD stock have an median target of 1, with a low estimate of 1 and a high estimate of 2. The median target predicts an increase of 127.27% from the current stock price of 0.44.

Analyst Consensus: Hold
Target Low Average Median High
Price $1 $1.33 $1 $2
Change 127.27% 202.27% 127.27% 354.55%

AI Analyst Report

According to 4 stock analyst, the rating for Relmada Therapeutics Inc. is "Hold". This means that the analyst believes this stock is likely to lead to similar returns than market as a whole.

Rating Jun 24Sep 24Dec 24
Strong Buy 010
Buy 000
Hold 002
Sell 100
Strong Sell 000
Total 1 1 2

Financial Forecast this Year

Revenue This Year
2.46M
from -
Increased by ∞B%
Revenue Next Year
10.00M
from 2.46M
Increased by 306.7%
EPS This Year
-1.15
from null
Increased by -∞B%
EPS Next Year
-1.36
from -1.15
Increased by -18.3%